I also suspect that the Nasdaq IPO will be delayed until Q1 2021. Which makes sense as hopefully we are annualising $20m in revenue by then based on what's been announced.
Plus add in FDA for the patch and NMPA for the prizma.
No wonder directors are pushing through these performance shares!!
- Forums
- ASX - By Stock
- GMV
- Ann: Four US university hospitals deploy GMV's IDTF platform
Ann: Four US university hospitals deploy GMV's IDTF platform, page-54
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)